Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Antonio Jimeno, MD, PhD
Anschutz Cancer Pavilion
Study Chair - Lawrence P. Leichman, MD
Academic Oncology Gastrointestinal Cancer Consortium
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
46 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Semmelweis University Department of Diagnostic Radiology and Oncotherapy
Budapest, Hungary
- Semmelweis University, 3rd Department of Internal Medicine
Budapest, Hungary
- Hetenyi Geza Hospital 5004, Szolnok, Hungary
Szolnok, Hungary
- Basavatarakam Indo-American Cancer Hospital
Hyderabad, Andhra Pradesh, India
- Regional Cancer Center
Thiruvananthapuram, Kerala, India
- Jaslok Hospital & Research Centre
Mumbai, Maharashtra, India
- Shatabdi Superspeciality Hospital
Nashik, Maharashtra, India
- Ruby Hall Clinic
Pune, Maharashtra, India
- Lifeline Multispeciality Hospitals
Chennai, Tamil Nadu, India
- State Budget Medical Institution of the Arkhangelsk Region
Arkhangelsk, Russia
- Chelyabinsk Regional Clinical Oncology Center
Chelyabinsk, Russia
- State Budget Medical Institution Clinical Oncology Center 1
Krasnodar, Russia
- Budget Medical Institution of the Omsk Region: Clinical Oncology Center
Omsk, Russia
- State Budget Medical Institution: Leningrad Regional Clinical Hospital
Saint Petersburg, Russia
- State Medical Institution: Tula Regional Oncology Center
Tula, Russia
- Zakarpattia Regional Clinical Oncology Center Department of Chemotherapy
Uzhhorod, Ukraine
- Ucsd Moores Cancer Center
La Jolla, California, United States
- Desert Comprehensive Cancer Center
Palm Springs, California, United States
- Pacific Cancer Care
Salinas, California, United States
- Premiere Oncology
Santa Monica, California, United States
- University of Colorado Cancer Center
Aurora, Colorado, United States
- Kaiser Permanente Colorado
Denver, Colorado, United States
- Poudre Valley Cancer Center of the Rockies
Fort Collins, Colorado, United States
- Yale Cancer Center
New Haven, Connecticut, United States
- Mount Sinai Comprehensive Cancer Center
Miami Beach, Florida, United States
- University of Hawaii Cancer Center
Honolulu, Hawaii, United States
- University of Kansas Cancer Center
Westwood, Kansas, United States
- Umass Medical School
Worcester, Massachusetts, United States
- Karmanos Cancer Institute
Detroit, Michigan, United States
- Billings Clinic Cancer Center
Billings, Montana, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- New York University Langone Medical Center
New York, New York, United States
- University of Rochester Medical Center
Rochester, New York, United States
- University of North Carolina Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
- Levine Cancer Institute
Charlotte, North Carolina, United States
- Cone Health Cancer Center
Greensboro, North Carolina, United States
- Hendersonville Hematology and Oncology at Pardee
Hendersonville, North Carolina, United States
- Rex Cancer Center Unc Healthcare
Raleigh, North Carolina, United States
- St. Alexis Medical Center-Mid Dakota Clinic Pc
Bismarck, North Dakota, United States
- University of Cincinnati Cancer Center
Cincinnati, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2011
- Primary completion
- 30 Jun 2015
- Completion
- 31 Dec 2015
- Last update posted
- 4 Aug 2016
- Registered enrollment
- 160
- Registry id
- NCT01360853
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.